Book a Meeting

Fc Engineered Anti-Human IGF1 Receptor Antibody, CDC-Enhanced (Biobet-C272ZP) (CAT#: Biobet-C272ZP) Datasheet

Target
IGF1 Receptor
Isotype
Human Therapeutic Antibody
Description
Fc Engineered Anti-Human IGF1 Receptor Antibody, CDC-Enhanced (Biobet-C272ZP) is a recombinant monoclonal Human antibody against IGF1 Receptor. This product is a CDC enhanced antibody produced by our proprietary platform.
Indication
Non-small cell lung cancers (NSCLC)
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced rituximab. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
IGF1R
Full Name
Insulin Like Growth Factor 1 Receptor
Background
This receptor binds insulin-like growth factor with a high affinity. It has tyrosine kinase activity. The insulin-like growth factor I receptor plays a critical role in transformation events. Cleavage of the precursor generates alpha and beta subunits. It is highly overexpressed in most malignant tissues where it functions as an anti-apoptotic agent by enhancing cell survival. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2014]
Gene ID
3480
UniProt ID
P08069
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
Human Therapeutic Antibody
Indication
Non-small cell lung cancers (NSCLC)

Non-small cell lung cancers (NSCLC)

Related Products

Fc Engineered Anti-Human IGF1 Receptor Antibody, CDC-Enhanced (Biobet-C274ZP) (CAT#: Biobet-C274ZP)
Fc Engineered Anti-Human IGF1 Receptor Antibody, CDC-Enhanced (Biobet-C273ZP) (CAT#: Biobet-C273ZP)

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.